Skip to main content
PRGO
NYSE Life Sciences

Perrigo Posts 20-Cent Loss Per Share in Third Quarter

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$15.7
Mkt Cap
$2.179B
52W Low
$9.225
52W High
$20.65
52W Position info
70% above low
Off High info
24% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

PRGO sits 70% above its 52-week low of $9.225.

Summary

Perrigo reported a third-quarter loss of 20 cents per share, a swing into the red for a company that posted $74.5 million of net income on $1.02 billion in sales in Q2. The quarter's loss was $27.5 million on sales of $988.6 million, with a loss from continuing operations of 10 cents per share and adjusted earnings of 60 cents per share. The loss lands as Perrigo is reshaping its portfolio, having agreed on October 29 to sell its infant formula business to MeridianMade for up to $175 million, with only $40 million of that in cash; beginning with the fourth quarter and full-year 2026 reporting, the infant formula business will be reported as discontinued operations. The company updated its full-year 2026 outlook to reflect the divestiture, more measured retailer inventory positioning, and continued softness in Europe, and reported sales declines across segments. A quarterly loss at a roughly $2.2 billion market cap company is material, and it comes with the stock already carrying takeover speculation after Betaville reported in October that CVC Capital may be evaluating a purchase to combine with its Cooper Consumer Health assets.

At the time of this announcement, PRGO was trading at $15.70 on NYSE in the Life Sciences sector, with a market capitalization of approximately $2.2B. The 52-week trading range was $9.23 to $20.65. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

PRGO - Latest Insights

PRGO
Nov 04, 2026, 12:54 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $16.47
Real-time Price: $16.04 info
Change: -$0.425 (-3%) info
Market Cap: $2.226B info
PRGO
Nov 04, 2026, 6:44 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $16.15
Real-time Price: $16.04 info
Change: -$0.110 (-0.68%) info
Market Cap: $2.226B info
PRGO
Nov 04, 2026, 6:41 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $16.15
Real-time Price: $16.04 info
Change: -$0.110 (-0.68%) info
Market Cap: $2.226B info
PRGO
Oct 29, 2026, 9:01 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $15.95
Real-time Price: $16.04 info
Change: +$0.090 (+0.56%) info
Market Cap: $2.226B info
PRGO
Oct 09, 2026, 4:17 PM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $15.09
Real-time Price: $16.04 info
Change: +$0.950 (+6%) info
Market Cap: $2.226B info